Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL6068431

BENZGALANTAMINE GLUCONATE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
COc1ccc2c3c1O[C@H]1C[C@@H](OC(=O)c4ccccc4)C=C[C@@]31CCN(C)C2.O=C(O)C(O)C(O)C(O)C(O)CO

Basic Information

ChEMBL ID CHEMBL6068431
Name BENZGALANTAMINE GLUCONATE
Phase Approved
Structure Type MOL
InChI Key YOMFDYFCNHSIAU-VXYIJGMPSA-N
Parent Compound CHEMBL5095056
Active Moiety CHEMBL5095056

Known Names

ALPHA-1062 gluconate Benzgalantamine gluconate Galantamine benzoate gluconate GLN-1062 gluconate Memogain gluconate Zunveyl
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
6
Known Names
3
Indications
1
Mechanisms

Molecular Properties

391.5
MW (Da)
3.72
ALogP
5
HBA
0
HBD
48.0
PSA (Ų)
0.59
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2024
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral
USAN Year 2024

Extended Properties

Molecular Formula C30H37NO11
MW 587.62
Aromatic Rings 2
Heavy Atoms 29
NP-Likeness 1.54

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Acetylcholinesterase inhibitor INHIBITOR Acetylcholinesterase

Indications

Dementia Alzheimer Disease Cognitive Dysfunction

Data from ChEMBL 36 via Core Engine